Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

AskBio

Biotech & Life Sciences · Durham, United States · Founded 2001 Unicorn

Biotechnology company engaged in the development and delivery of novel protein

Valuation
$2.5–5B
Latest valuation · 2026
Unlock exact value
Headcount
500–1k
Current team size
Unlock exact value

Investors

2 investors on AskBio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
Vida Ventures
TPG

Global footprint

Where AskBio has talent and traffic

AI talent share
0.8% of workforce is AI talent
(4 of 505 staff)
Core AI10.2%
Other AI30.59%
Non-AI workforce50199.21%
Workforce by country
7 countries with
team presence
🇺🇸 United States81.1%
🇬🇧 United Kingdom10.1%
🇫🇷 France4.6%
🇩🇪 Germany3.2%
🇪🇸 Spain0.8%
Top 5 of 7 shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States55%
🇬🇧 United Kingdom20%
🇮🇳 India12.5%
🇯🇵 Japan5%
🇪🇸 Spain5%
Top 5 markets shown

Patent intelligence

$14M patent portfolio · 42 active families

Estimated portfolio value
$14M
0.35% of valuation · 16.1× smaller than top peer Arvinas ($223M)
42 active patent families
Where AskBio innovates Heart failureDrugEnergy reservesProtein expressionHomeostasis

Where AskBio concentrates vs peers

Each axis is a top-10 topic across AskBio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

AskBio's 3 investments and acquisitions.

Every disclosed deal where AskBio appeared as a backer or acquirer, 2019–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across AskBio's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        AskBio's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about AskBio

        An AI-synthesized read of the highest-engagement posts about AskBio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See AskBio on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.